Investing Profile

Stephen Knight

InvestorVC
President and Managing Partner at F-Prime Capital Partners
fprimecapital.com/people/step...Cambridge, Massachusetts
Photo of Stephen Knight, Managing Partner at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
F-Prime Capital Partners Managing Partner
$100K - $10.0M
$5.0M
16
CompanyStageDateRound SizeTotal Raised
Atalanta Therapeutics
Series BJan 2025$97M
Series AJan 2021$110M
$210M
Co-investors: Jessica Alston (F-Prime Capital Partners), Stacie Weninger (F-Prime Capital Partners), Niall O’Donnell (RiverVest), Jason P. Hafler (Sanofi Ventures)
Quantum Circuits, Inc.
Series BMay 2024$60M
$78M
Co-investors: Bill Coughran (Sequoia Capital), Brendan Dickinson (Canaan Partners), Eugene Chiu (In-Q-Tel), Corey Ritter (ARCH Venture Partners)
Genomics
Series CJan 2024$45M
Series UnknownMar 2021$30M
Series BDec 2018$9M
$84M
Co-investors: Jim Tananbaum (Foresite Capital)
Paradigm
Series AJan 2023$200M
$250M
Co-investors: Hemant Taneja (General Catalyst), Elena Viboch (General Catalyst), Niko Bonatsos (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Alaa Halawa (Mubadala), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Jared Friedman (Y Combinator), Arash Ferdowsi, Eoghan McCabe, Balaji Srinivasan, Scott Belsky
Ensoma
Series BJan 2023$85M
Series AFeb 2021$70M
$210M
Co-investors: Kush Parmar (5am Ventures), Kouki Harasaki (Bioluminescence Ventures), Mark Chin (Arix Bioscience)
Aerium Therapeutics
Series AMar 2022
Co-investors: Michael Powell (Omega Funds), Vincent Ossipow (Omega Funds)
Leyden Labs
Series BJan 2022$140M
Series AMar 2021$47M
$260M
Co-investors: David Schenkein (GV (Google Ventures)), Brook Byers (Kleiner Perkins), Nisa Leung (Qiming Venture Partners)
Prime Medicine
Series BJul 2021$200M
Series AOct 2019$120M
$320M
Co-investors: David Schenkein (GV (Google Ventures)), Stephen Francis (Arrive), Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive)